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Obesity and Insulin Resistance Are Inversely Associated with Serum and Adipose
Tissue Carotenoid Concentrations in Adults
Abstract
Background
Low tissue concentrations of carotenoids have been suggested to contribute to insulin resistance in
obesity. Objectives
The objectives of the study were to 1) evaluate the relations of adipose tissue and serum carotenoids
with body fat, abdominal fat distribution, muscle, adipose tissue and liver insulin resistance, and dietary
intake; 2) evaluate the relations and distributions of carotenoids detected in adipose tissue and serum;
and 3) compare serum carotenoids and retinol concentrations in subjects with and without obesity.
Methods
Post hoc analysis of serum and adipose tissue carotenoids in individuals [n = 80; 31 men, 49 women; age
(mean ± SEM): 51.4 ± 1.1 y] who participated in 2 separate studies conducted at the Clinical Research
Facility at the Garvan Institute of Medical Research (Sydney) between 2008 and 2013. Retinol, α-carotene,
β-carotene, ζ-carotene, lutein, lycopene, phytoene, and phytofluene were measured using HPLC. Body
composition was measured by dual-energy X-ray absorptiometry. Insulin resistance was measured by
2-step hyperinsulinemic-euglycemic clamps with deuterated glucose (n = 64), and subcutaneous and
visceral abdominal volume and liver and pancreatic fat by MRI (n = 60). Periumbilical subcutaneous fat
biopsy was performed and carotenoids and retinol measured in the tissue (n = 16). Results
We found that ζ-carotene, phytoene, and phytofluene were stored in considerable amounts in adipose
tissue (25% of adipose tissue carotenoids). Carotenoid concentrations in adipose tissue and serum
correlated significantly, but they followed different distributions: ζ-carotene was 3-fold higher in adipose
tissue compared with serum, while lutein and lycopene made up 20% and 21% of serum carotenoids
compared with 2% and 12% of adipose tissue carotenoids, respectively. Liver (P ≤ 0.028) and adipose
tissue (P = 0.023), but not muscle (P ≥ 0.16), insulin resistance correlated inversely with many of the
serum carotenoids. Conclusions
Multiple serum and adipose tissue carotenoids are associated with favorable metabolic traits, including
insulin sensitivity in liver and adipose tissue in humans.
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ABSTRACT
Background: Low tissue concentrations of carotenoids have been suggested to contribute to insulin resistance in
obesity.
Objectives: The objectives of the study were to 1) evaluate the relations of adipose tissue and serum carotenoids with
body fat, abdominal fat distribution, muscle, adipose tissue and liver insulin resistance, and dietary intake; 2) evaluate
the relations and distributions of carotenoids detected in adipose tissue and serum; and 3) compare serum carotenoids
and retinol concentrations in subjects with and without obesity.
Methods: Post hoc analysis of serum and adipose tissue carotenoids in individuals [n = 80; 31 men, 49 women; age
(mean ± SEM): 51.4 ± 1.1 y] who participated in 2 separate studies conducted at the Clinical Research Facility at the
Garvan Institute of Medical Research (Sydney) between 2008 and 2013. Retinol, α-carotene, β-carotene, ζ -carotene,
lutein, lycopene, phytoene, and phytofluene were measured using HPLC. Body composition was measured by dualenergy X-ray absorptiometry. Insulin resistance was measured by 2-step hyperinsulinemic-euglycemic clamps with
deuterated glucose (n = 64), and subcutaneous and visceral abdominal volume and liver and pancreatic fat by MRI
(n = 60). Periumbilical subcutaneous fat biopsy was performed and carotenoids and retinol measured in the tissue
(n = 16).
Results: We found that ζ -carotene, phytoene, and phytofluene were stored in considerable amounts in adipose tissue
(25% of adipose tissue carotenoids). Carotenoid concentrations in adipose tissue and serum correlated significantly, but
they followed different distributions: ζ -carotene was 3-fold higher in adipose tissue compared with serum, while lutein
and lycopene made up 20% and 21% of serum carotenoids compared with 2% and 12% of adipose tissue carotenoids,
respectively. Liver (P ≤ 0.028) and adipose tissue (P = 0.023), but not muscle (P ≥ 0.16), insulin resistance correlated
inversely with many of the serum carotenoids.
Conclusions: Multiple serum and adipose tissue carotenoids are associated with favorable metabolic traits, including
insulin sensitivity in liver and adipose tissue in humans. J Nutr 2020;150:38–46.

Keywords: carotenoids, retinol, obesity, insulin resistance, dietary carotene, adipose tissue carotenoids, serum
carotenoids

Introduction
Carotenoids are natural pigments, mainly absorbed from
vegetables and fruit in the diet and cannot be synthesized in
the human body (1). Liver and adipose tissue are main sites
of carotenoid accumulation (2, 3), and it has been suggested
that carotenoids and their metabolites play a role in metabolic
processes within these tissues (4). Nutritional deficiencies in

carotenoids and low serum concentrations of carotenoids were
documented in obesity (5, 6), but it remains unclear whether
lower concentrations of carotenoids in tissues in obesity are
associated with glucose dysregulation in adipose tissue, liver,
and muscle.
Lower serum carotenoids were reported in children, adolescents, and adults with overweight and obesity (6–9) and in type
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Methods
This study consisted of 2 separate cohorts studied at the Garvan
Institute of Medical Research Clinical Research Facility (Sydney,
Australia) between 2008 and 2013 (Figure 1). The protocols were
approved by the St Vincent’s Hospital Human Research Ethics
Committee (Sydney, Australia), and written consent was obtained prior
to study commencement.

Subjects
Adult men and women were recruited through advertisements in
local newspapers and at the Garvan Institute of Medical Research/St
Vincent’s Hospital precinct (Sydney). Inclusion criteria for the 2 studies
were similar and included age 18–70 y and individuals had to maintain
a relatively sedentary lifestyle (moderate/high-intensity exercise under
150 min per week). Exclusion criteria were treatment with medications
known to affect glucose metabolism (glucose lowering, glucocorticoids);
The clinical studies were funded by grants from the Diabetes Australia Research
Program and the Garvan Research Foundation.
Author disclosures: AH, ACFC, AJ, AX, JRG, DH, AS, and DS-B, no conflicts of
interest.
Supplemental Figure 1 and Supplemental Table 1 are available from the
“Supplementary data” link in the online posting of the article and from the same
link in the online table of contents at https://academic.oup.com/jn.
AS and DS-B contributed equally to this work.
Address correspondence to DS-B (e-mail: d.samochabonet@garvan.org.au).
Abbreviations used: CRP, C-reactive protein; DDW, double distilled water;
DXA, dual-energy X-ray absorptiometry; EGP, endogenous glucose production;
HbA1c, glycated hemoglobin; NEFA, nonesterified fatty acid; RBP, retinol binding
protein.

FIGURE 1 Participant flowchart. Serum and adipose tissue
carotenoids and retinol were analyzed in samples collected in
2 separate cohorts recruited at the Clinical Research Facility at
the Garvan Institute of Medical Research between 2008 and 2013.
Protocols performed and number of participants are listed in the
boxes. OGTT, oral-glucose-tolerance test.
excessive alcohol intake; weight change >5% in the 3 mo leading
up to the study; renal, cardiac, or liver disease; diabetes; and cancer.
Subjects underwent a 75-g oral-glucose-tolerance test, and participants
with diabetes were excluded using the American Diabetes Association
criteria. Cohort 1 (n = 16) consisted of individuals with BMI ranging
from 18.5 to 35.6 kg/m2 and cohort 2 (n = 64) consisted of
individuals with obesity (BMI ranging from 30.1 to 48.5 kg/m2 ) (24).
All participants were Caucasian.

Study protocols
In both studies, participants arrived at the Clinical Research Facility
early in the morning after overnight fasting, and measurements of blood
pressure and anthropometry were undertaken.

Muscle, liver, and adipose tissue insulin resistance
The 2-step hyperinsulinemic-euglycemic clamp with deuterated glucose
(D-glucose; Cambridge Isotope Laboratories) was performed in cohort
2, as previously described (24). Endogenous glucose production (EGP)
was calculated as described (24) and reflects hepatic insulin resistance.
Glucose infusion rate was calculated at 90–120 min of the high-dose
insulin clamp, and M-value was calculated by dividing the glucose
infusion rate by body fat-free mass. Since EGP was fully suppressed
during the high-dose insulin infusion, M-value reflects peripheral
(mainly muscle) insulin resistance (24). Adipose tissue insulin resistance
was calculated by the suppression of nonesterified fatty acid (NEFA)
from baseline to the low-dose insulin clamp steady state (NEFA
suppression) (24). A surrogate of adipose tissue insulin resistance was
calculated as the product of fasting circulating NEFA and insulin (25).
For 2 subjects, liver insulin resistance could not be calculated due to
plasma tracer sampling or analysis errors; therefore, basal EGP data are
available for n = 62.

Body fat composition and abdominal fat distribution
Body fat and fat-free mass were measured by dual-energy X-ray
absorptiometry (DXA) (Lunar Prodigy; GE-Lunar) in both cohorts.
Cohort 2 had further quantification of abdominal fat depots by MRI
(3.0 T Philips Achieva) to evaluate visceral, subcutaneous, liver, and
pancreas fat, as previously described (24). DXA and MRI data are
available on n = 79 and n = 61, respectively.
Serum and fat carotenoids and insulin resistance 39
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2 diabetes (10, 11); and plasma carotenoids concentrations were
associated inversely with fasting insulin, glycated hemoglobin
(HbA1c), and the insulin resistance surrogate HOMA-IR (12,
13). Retinol may originate in the diet or generated de novo
from α-carotene, β-carotene, and β-cryptoxanthin. Retinol can
be metabolized to retinoic acid, ligand for nuclear receptors
involved in transcription of genes implicated in metabolic
pathways (14). Findings regarding the relation between serum
retinol, obesity, and type 2 diabetes in humans are inconsistent.
Some studies suggested reduced (15, 16), others indicated
elevated (12, 17), and some did not find significant changes (10,
18) in retinol status in obesity and type 2 diabetes.
Studies in cell cultures and rodents highlighted the role of
carotenoids and their metabolites in adipose tissue secretion
of adipokines, adipogenesis, and inflammation (14, 19, 20).
BMI and waist circumference were inversely associated with
adipose tissue content of α- and β-carotene and lycopene
(21), and carotenoids in fat tissue sampled from the abdomen,
buttock, and thigh were inversely related to body fat mass (22).
Furthermore, β-carotene content in subcutaneous adipocytes
collected in subjects with obesity were half that measured in
adipocytes collected in individuals who were of normal weight
(23). In most previous studies, limited number of carotenoids
have been analyzed and many not reported.
In the present study, we measured 7 carotenoids and their
isomers in subcutaneous abdominal adipose tissue and serum
in men and women with a wide range of BMI. Our aims
were to 1) study the associations between adipose tissue and
serum carotenoids and retinol status with body fat composition,
abdominal fat distribution, circulating metabolic markers,
glucose regulation, and dietary intake; 2) evaluate the relations
and distributions of carotenoids detected in adipose tissue
and serum; and 3) compare serum carotenoids and retinol
concentrations between individuals with or without obesity.

TABLE 1 Clinical and metabolic characteristics of the nonobese and obese subcohorts1
Characteristic

1

A needle biopsy of periumbilical subcutaneous fat was performed
in cohort 1, as previously described (26), and ∼150 mg of tissue
obtained, snap-frozen in liquid nitrogen, and stored at –80◦ C until
analyzed.

Biochemical measurements in blood
Whole-blood glucose was measured using the YSI 2300 STAT analyzer.
Serum insulin was measured by radioimmunoassay (Millipore). Serum
lipid profile was analyzed by an automated analyzer (Advia 2400
Chemistry System; Siemens Medical Solutions Diagnostics), with LDL
cholesterol calculated using the Friedewald equation. NEFAs were
measured by an enzymatic colorimetric assay (Wako), and highsensitivity C-reactive protein (CRP), fibroblast growth factors 19 and
21, total adiponectin, fatty acid binding protein 4, lipocalin 2, and
retinol binding protein (RBP) 4 were measured by ELISA (Antibody and
Immunoassay Service, University of Hong Kong, available in cohort 2,
n = 64), as previously described (24). Fasting plasma glucose, serum
insulin, and serum lipid profile data are available on n = 76, n = 80,
and n = 79, respectively.

Dietary intake analysis
Dietary intake was evaluated using diet diaries (2 d) analyzed using
the Australian-based food composition software FoodWorks 7 (Xyris),
available in cohort 2 (n = 64).

Carotenoid and retinol measurements

All tissues were stored at –80◦ C and analyzed together. Serum
(0.5 mL) and adipose tissue (∼150 mg) samples were extracted with
2 mL ethanol containing 10 μM butylated hydroxytoluene. After the
addition of 2 mL hexane and 1 mL double distilled water (DDW), the
samples were mixed and centrifuged for 5 min at 1000 × g at 4◦ C.
The hexane layer of serum samples was divided into 2 aliquots, 1 for
retinol and 1 for carotenoid detection. The hexane layers of the adipose
tissue samples were saponified with 12% KOH in absolute ETOH
for 30 min at 50◦ C. After washing twice with 2 mL saline, followed
by centrifugation, the hexane layer was dried in N2 . Dried samples
were suspended in 100 μL tert-butyl methyl ether for carotenoid and
100 μL methanol for retinol detection. Retinol concentrations were
determined by reverse-phase HPLC on a Vydac C18 column (201TP-54,
250 × 5 mm, 5-μm particle size; Vydac), with methanol/butanol/water
+ 10 mM ammonium acetate as the mobile phase at a flow rate
of 0.8 mL/min. Retinyl acetate was used as an internal standard
for retinol detection. Serum carotenoids were determined by reversephase HPLC on a YMC C30 column (CT995031546QT, 150 × 4.6,
3-μm particle size; YMC, Inc.) with a gradient, as described (27).
Harari et al.

P value

14 (2/12)
55.4 ± 2.4
127 (116, 138)
75 ± 3
37 ± 3
1.7 ± 0.2
4.7 ± 0.1
6.9 ± 0.3
5.6 ± 0.2
7.8 (5.8, 10.7)
1.6 (0.9, 2.3)
4.7 ± 0.3
1.1 ± 0.2
1.6 ± 0.1
2.7 ± 0.3

66 (29/37)
50.9 ± 1.4
124 (116, 134)
83 ± 1
46 ± 1
3.4 ± 0.1
4.8 ± 0.1
7.8 ± 0.3
6.3 ± 0.2
15.3 (11.3, 23.3)
4.1 (2.4, 5.0)
4.8 ± 0.1
1.0 ± 0.1
1.3 ± 0.0
3.0 ± 0.1

0.14
0.504
0.013
<0.001
<0.001
0.703
0.037
0.027
<0.001
<0.001
0.753
0.970
0.033
0.184

Data are mean ± SEM or median (IQR) for variables not normally distributed. OGTT, oral-glucose-tolerance test.

Adipose tissue biopsy

40

BMI >30 kg/m2

Adipose tissue carotenoids were determined by reverse-phase HPLC
on a YMC C30 column with methanol/DDW/methyl-tert-buthyl-ether,
according to Colmán-Martínez et al. (28). Carotenoids were detected
by monitoring absorbance and by comparison with the retention times
of authentic standards (95%–98% purity; CaroteNature, Switzerland).
Absorbance was detected at a wavelength of 200 to 700 nm to identify
carotenoids with absorption in the UV range and the visible range
of the spectrum. HPLC analyses are available on serum collected in
both cohorts (n = 80) and adipose tissue biopsy specimens collected
in cohort 1 (n = 16). We identified and quantified several stereoisomers
of carotenoids in serum and adipose tissue and report the results of total
concentrations of each carotenoid.

Statistical analysis
For the sake of the post hoc analyses of serum and adipose tissue
carotenoids, the 2 cohorts comprising this study were combined for
continuous analysis. Although the BMI values of the 2 cohorts had
different ranges, there was overlap. All the data for those subjects with
BMI in the overlapping range (i.e., high BMI cohort 2 subjects and low
BMI cohort 1 subjects) were similarly distributed.
The data for each variable were tested for normality via the
Anderson-Darling, Kolmogorov-Smirnov, and Lilliefors tests. If any of
the tests showed nonnormality, then the logged values of the variable
were used. The variables fell into several broad classes, and these were
uniformly treated as all log-normal or normally distributed, based on
the results for the majority of the class components. The variables
that were treated as log-normal were body fat, glucose regulation,
circulating metabolites, diet, and all carotenoids (both serum and
adipose tissue). All statistical testing, outlined below, was performed on
the original values for the normally distributed variables and on the
logged values for the log-normal variables. The data for participants
in cross-sectional analyses were divided into 2 groups: BMI ≤30 kg/m2
and BMI > 30 kg/m2 . The clinical data (Table 1) were tested by t test for
normally distributed data or the Mann-Whitney U test for nonnormally
distributed data. The serum carotenoids data in the cross-sectional
analysis for each variable and each group were analyzed to check for
homoscedasticity using a Bartlett test. For equal variances, a 1-way
ANOVA was determined; otherwise, a Welsh’s ANOVA was calculated
to determine significant differences between the groups (equivalent to
a 2-tailed t test, with appropriate adjustments for homoscedasticity). In
all cases, the significance cutoff was 0.05. For the correlation analyses
between variables, the Pearson correlation coefficients were calculated
between the different quantities.
Statistical analyses were implemented in MATLAB (R2018b;
Mathworks, Inc.).
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n (male/female)
Age, y
Systolic blood pressure, mm Hg
Diastolic blood pressure, mm Hg
Total body fat, %
Central body fat, kg
Fasting blood glucose, mmol/L
Glucose: 1-h OGTT, mmol/L
Glucose: 2-h OGTT, mmol/L
Fasting serum insulin, mU/L
HOMA-IR
Total cholesterol, mmol/L
Triglycerides, mmol/L
HDL cholesterol, mmol/L
LDL cholesterol, mmol/L

BMI ≤30 kg/m2

Results

Serum carotenoids and adiposity
Participants were stratified based on BMI as nonobese
(≤30 kg/m2 ) or obese (>30 kg/m2 ). Age, systolic blood
pressure, fasting glucose, total cholesterol, LDL cholesterol, and
triglycerides were not significantly different between the groups
(Table 1). Diastolic blood pressure, total body fat, central fat,
glucose concentration 1 and 2 hours after the 75-g glucose
load, fasting serum insulin, and HOMA-IR were all elevated in
individuals with obesity, and HDL cholesterol was higher in the
nonobese group (Table 1).
All measured serum carotenoids were significantly lower
in samples collected from individuals with obesity compared
with individuals without obesity (Figure 3A–G). Serum retinol
concentrations were not significantly different between the
groups (Figure 3H), and retinol-to-β-carotene ratio was higher
in the obese group (Figure 3I).
Serum and adipose tissue carotenoids and
anthropometric measures
All serum-measured carotenoids, α-carotene, β-carotene, and ζ carotene, lutein, and lycopene, correlated inversely with some or
all of the anthropometric and body composition measurements
(e.g., weight, BMI, waist circumference, total body fat, body
fat-free mass, and central body fat; Figure 2C). Neither the
carotenoids nor retinol measured in serum correlated with
fat in the liver, pancreas, or the size of the subcutaneous
and visceral abdominal depots measured by MRI (P ≥ 0.07).
Serum retinol did not correlate with any of the anthropometric
measurements. Similar to serum carotenoids, most adipose
tissue carotenoids associated inversely with anthropometric
measures, including weight, BMI, waist circumference, and
DXA-derived total and central body fat. Adipose tissue βcarotene was the only carotenoid that did not show any
correlation with the anthropometric measurements (Figure 2D).

Serum carotenoids and glucose regulation
Total carotenoids, β-carotene, and α-carotene showed inverse
associations with fasting insulin and HOMA-IR. However,
HbA1c, a 3-month glycemic control marker, did not significantly correlate with most carotenoids, except for ζ -carotene,
which tended to inversely associate with HbA1c (r = –0.23,
P = 0.069) (Figure 2C). β-Carotene, α-carotene, and total
carotenoids correlated inversely with liver insulin resistance
(basal EGP, Figure 2C); however, none of the carotenoids
correlated with muscle insulin resistance (P ≥ 0.16). Adipose
tissue insulin resistance, measured by the product of fasting
serum NEFA and insulin, correlated inversely with the total
concentration of the carotenoids and tended to correlate
inversely with β-carotene and with the sum of α- and β-carotene
(r = –0.24, P = 0.055 and r = –0.24, P = 0.052, respectively)
(Figure 2C). Similarly, NEFA suppression, an inverse measure of
adipose tissue insulin resistance, tended to positively associate
with serum β-carotene and with the sum of α- and β-carotene
(r = 0.24, P = 0.056 and r = 0.25, P = 0.050, respectively)
(Figure 2C). The ratio of retinol to β-carotene in serum
correlated positively with fasting insulin, HOMA-IR, and basal
EGP, while NEFA suppression tended to inversely associate
with retinol to β-carotene (r = –0.24; P = 0.057) (Figure 2C).
Similarly, the ratio of dietary retinol to β-carotene correlated
inversely with NEFA suppression (r = –0.40, P = 0.0011; data
not shown).
Serum carotenoids and dietary macro- and
micronutrients
Daily energy intake and diet composition are provided in
Supplemental Table 1. Serum α-carotene correlated inversely
with carbohydrate intake (proportion of total daily energy),
and all serum carotenoids correlated positively with dietary
PUFA intake (proportion of total fat intake). Most carotenoids
Serum and fat carotenoids and insulin resistance 41
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Serum and adipose tissue carotenoids distribution
and relations
All carotenoids detected in serum were also detected in adipose
tissue. We measured concentrations of 5 serum carotenoids
(α-carotene, β-carotene, lutein, lycopene, and ζ -carotene) and
retinol. We identified 1 isomer of β- and α-carotene, 2 isomers
of lutein and lycopene, and 3 isomers of ζ -carotene in serum
(Supplemental Figure 1A). According to absorption spectra,
additional isomers of these carotenoids were also present,
but the identification is not certain or below the limit of
detection. Seven carotenoids were measured in adipose tissue.
β-Carotene, lutein, and phytoene had 1 isomer each; α-carotene
and lycopene had 2 isomers each; and phytofluene and ζ carotene each had 4 isomers detected (Supplemental Figure 1B).
The distribution of adipose tissue and serum carotenoids
followed a different pattern (Figure 2A). In adipose tissue,
phytoene and phytofluene made up 25% of adipose tissue
carotenoids but were under the limit of detection in serum. The
proportion of ζ -carotene in adipose tissue was ∼3-fold that in
serum, while lutein and lycopene, comprising 20% and 21%
of serum carotenoids, respectively, made up 2% and 12% in
adipose tissue, respectively (Figure 2A).
Serum and adipose tissue carotenoids mostly correlated
positively with their own concentration in the other tissue
or with each other, except for β-carotene and retinol, which
correlated neither with their own concentrations nor with other
carotenoids in the other tissue (Figure 2B).

Serum and adipose tissue carotenoids, cardiovascular
risk markers, and cytokines
Serum α-, β-, and ζ -carotene and retinol correlated inversely
with diastolic blood pressure, but none of the carotenoids and
retinol correlated with systolic blood pressure (Figure 2C).
Similarly, adipose tissue α-carotene, ζ -carotene, phytoene,
phytofluene, and total carotenoids correlated inversely with
diastolic blood pressure (Figure 2D).
Serum β-carotene and the sum of α + β-carotene correlated
inversely with serum triglycerides and triglyceride–to–HDL
cholesterol ratio, while total serum carotenoids and serum
triglycerides tended to inversely associate (r = –0.22, P = 0.051;
Figure 2C). Retinol–to–β-carotene ratio correlated positively
with serum triglycerides and triglycerides–to–HDL cholesterol
ratio. Serum retinol and triglycerides tended to be positively
associated (r = 0.22, P = 0.051; Figure 2C). Adipose tissue
ζ -carotene correlated inversely with serum triglycerides and
phytofluene, and total carotenoids tended to be inversely
associated with serum triglycerides (r = –0.50, P = 0.058; r =
–0.49, P = 0.064, respectively; Figure 2D).
Serum lycopene correlated inversely with CRP, while
serum ζ -carotene tended to associate inversely with CRP
(r = –0.024, P = 0.058; Figure 2C). Serum retinol to β-carotene
correlated inversely with adiponectin. Serum β-carotene tended
to associate positively with adiponectin (r = 0.23, P = 0.067;
Figure 2C), while the ratio of dietary retinol to β-carotene
correlated inversely with adiponectin (r = –0.28, P = 0.028;
data not shown). RBP4, the carrier of retinol in the circulation,
correlated positively with serum retinol (Figure 2C).
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FIGURE 2 Distribution of carotenoids in serum and adipose tissue (A) and relations between serum and adipose tissue carotenoids (B); serum
carotenoids, metabolic markers, and dietary intake (C); and between adipose tissue carotenoids and metabolic markers (D). In panels B to D,
if 0 ≤ P < 0.05, then the r value of the correlation is shown using a solid color. If 0.05 ≤ P < 0.07, then the r value of the correlation is shown
as a hatched box in the appropriate color. The correlation coefficient is indicated using the color scale. For panels B and D, data are available for
individuals who had both adipose tissue and serum collected (n = 16).
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correlated inversely with SFA intake (proportion of total
fat intake). α-Carotene, ζ -carotene, lutein, and the total
carotenoids correlated positively with the dietary omega-3
PUFA intake (Figure 2C). Dietary retinol to β-carotene intake
correlated positively with the ratio of retinol to β-carotene
in serum and inversely with β-carotene, α + β-carotene, and
total carotenoids. However, dietary intake of retinol, retinol
equivalents, and β-carotene did not correlate with any of the
serum retinol and carotenoids measured.

Discussion
We performed a comprehensive analysis of serum and adipose
tissue carotenoids and applied gold-standard measures of
abdominal fat distribution and tissue-specific insulin resistance
in nondiabetic subjects with a wide range of BMI and
insulin resistance. We detected several carotenoids in serum
and adipose tissue, including α- and β-carotene, lutein, and
lycopene. We report, for the first time, to our knowledge, the
associations between adipose tissue ζ -carotene, phytoene and
phytofluene, and adiposity and insulin resistance in humans. We
show that these carotenoids and their stereoisomers are major

components of carotenoids accumulated in adipose tissue.
We find that adipose tissue and serum carotenoids correlate
positively but follow different distributions in these tissues.
We show that multiple serum and adipose tissue carotenoids
are associated with favorable metabolic traits, including lower
adiposity and insulin sensitivity in liver and adipose tissue in
humans.
All serum carotenoids detected in the present study were
significantly lower in individuals with obesity, and while
retinol concentration was not different between the groups,
the ratio of serum retinol to β-carotene was higher in obesity.
Previous studies reported inverse associations between serum
carotenoids, particularly α- and β-carotene, and BMI or waist
circumference (6–8). Furthermore, fat mass was inversely
correlated with serum α- and β-carotene in children (6), while in
postmenopausal women, serum α-carotene correlated inversely
with body fat mass, while β-carotene, lutein, and lycopene did
not (29). No associations were found between serum lutein,
zeaxanthin, and body fat (30). Chung et al. (22) reported
inverse associations between some carotenoids in adipose tissue
and body fat in 25 healthy subjects. Here, we report that
most carotenoids detected in serum and in adipose tissue
correlated inversely with total body fat content and central
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FIGURE 3 (A–I) Cross-sectional analysis of serum carotenoid concentrations in obese compared with nonobese individuals. All the data points
are shown. The boxes indicate the retransformed (nonlogged) values of q1 , q2 , and q3 . The whiskers indicate the retransformed range of less
than q3 + 1.5(q3 − q1 ) and greater than q1 − 1.5(q3 − q1 ). P values are indicated on the panels. BMI ≤30 kg/m2 , n = 14; BMI >30 kg/m2 ,
n = 63–66.
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X receptor, while all-trans retinoic acid does not (34). Therefore,
it is plausible that different isomers of carotenoids have different
roles in the human body.
While serum carotenoids correlated inversely with many
parameters of body fat composition, glucose regulation, and
cardiometabolic risk factors, retinol did not correlate with
any of these parameters, apart from diastolic blood pressure
(negative) and with its plasma carrier RBP4 (positive). The lack
of associations between serum retinol and metabolic parameters
is consistent with some other reports (10, 18). Serum retinol
concentrations are kept at a narrow range due to homeostatic
regulation, and its serum concentration does not always respond
to oral supplementation (45, 46). Similarly, in animal models,
lower liver retinol concentration was not mirrored in the serum
(2). While serum retinol per se did not correlate with glucose
regulation in the present study, the ratio of retinol to βcarotene in serum correlated with adverse glucose regulation,
particularly liver insulin resistance. Together with the relation
between dietary retinol to β-carotene and adipose tissue insulin
resistance observed here, high dietary intake of carotenoids
(found in fruit and vegetables), coupled with low intake of
dietary sources of retinol (found in high-fat meat and dairy
products), may be advisable.
Finally, we aimed to evaluate the correlations between
adipose tissue and serum carotenoids and to investigate their
distribution in these tissues. It was suggested that circulating carotenoids reflect short-term carotenoid status, while
adipose tissue carotenoids reflect long-term carotenoid status
(47). Previous studies reported that abdominal adipose tissue
carotenoids were positively related with serum carotenoids
in men and women with normal weight (22, 43). We
found that subcutaneous adipose tissue carotenoids, except βcarotene, correlated significantly with serum carotenoids, but
the distribution of carotenoids in serum and adipose tissue
followed different patterns. Using a high-throughput HPLC
method, we report for the first time, to our knowledge, that ζ carotene, phytoene, and phytofluene are carotenoids stored in
considerable amounts in adipose tissue in human. ζ -Carotene,
phytoene, and phytofluene are carotenoids found in vegetables
and fruit, including tomato and, in lesser amounts, papaya,
pink grapefruit, and apricot (48). Tomato and tomato product
consumption was associated with lower cardiovascular and
cancer risk in large cohort epidemiological studies, and this
protective effect was attributed to lycopene, a main carotenoid
in tomato (49, 50); however, the role of other carotenoids found
in tomato was not investigated.
The strengths of our study are the detailed glucose
regulation and body fat distribution testing, with goldstandard methods and adipose tissue biopsies. The use of the
2-step hyperinsulinemic-euglycemic clamp with glucose tracers
enabled the investigation of key tissues participating in wholebody glucose regulation, muscle, liver, and adipose tissue.
Furthermore, our high-throughput HPLC method enabled the
detection of numerous carotenoids not previously reported
in serum and adipose tissue and their isomers, providing a
comprehensive overview of carotenoid status in humans.
Our study has several limitations. First, some of the
data were available on a relatively small cohort, and in the
cross-sectional analysis, the subcohorts were of unequal size.
Furthermore, we relied on diet diaries known to be confounded
by inaccuracies, particularly in cohorts with overweight and
obesity (51). Finally, we identified several stereoisomers of
carotenoids based on absorption spectra and proximity to the
major isomer, rather than relying on standards, due to lack of
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fat, as measured by DXA. However, unlike findings in children
with obesity (31), none of the serum carotenoids measured here
correlated significantly with the abdominal subcutaneous or
visceral fat depots specifically (measured by MRI).
We used a gold-standard method to evaluate muscle and liver
insulin resistance. We found that total carotenoids and the pro–
vitamin A precursors α- and β-carotene correlated inversely
with liver and adipose tissue insulin resistance. However, none
of the carotenoids correlated with muscle insulin resistance.
Liver and adipose tissue are main sites of carotenoid accumulation (2, 32), and our findings may suggest that carotenoids
play an insulin-sensitizing role locally in these tissues, but
may also serve as markers of increased insulin sensitivity. In
rodent models of obesity and atherosclerosis, we have reported
that supplementing the diet with β-carotene decreased lipid
deposition in the liver and blunted glucose excursions after
an intraperitoneal glucose load. This was associated with
downregulation of adipose tissue and liver mRNA expression
of proinflammatory genes (20, 33). The possible protective
effect of carotenoids on insulin resistance could stem from
the capacity of α- and β-carotene to serve as retinoic acid
precursors. Retinoic acid, a ligand for the nuclear receptors
retinoic acid receptor and retinoid X receptor that form a
heterodimer with peroxisome proliferator–activated receptor γ
and other nuclear receptors, may play a role in whole-body
glucose regulation, either by enhancing insulin sensitivity or
by potentiating insulin release (34–36). Another mechanism
proposed for the protective role of carotenoids is through their
antioxidative capacity (37, 38). Indeed, oxidative stress and
low-grade inflammation are hallmarks of obesity (39), and
carotenoids have been suggested to possess antioxidative and
anti-inflammatory properties (40). The associations reported
here between serum carotenoids, CRP, and adiponectin may
support this notion and are consistent with previous findings
reporting inverse associations between plasma concentrations
of carotenoids and IL-6, CRP, TNF-α, and RBP4 (41, 42).
The exact mechanisms explaining the lower concentrations
of carotenoids in obesity are unclear. Lower plasma carotenoids
may be a marker of a low-quality diet, depleted in carotenoids
(43). Indeed, we found that plasma carotenoids correlated
positively with PUFA intake and inversely with SFA intake, and
the ratio of dietary retinol/β-carotene correlated significantly
with serum carotenoids and retinol concentrations. Since
carotenoids are lipid soluble, it has been suggested that
adipose tissue may act as a sink for circulating carotenoids
(14, 44). However, our findings of lower carotenoids in
adipose tissue in subjects with obesity would contradict this
notion. Indeed, Osth et al. (23) have demonstrated that the
concentration of β-carotene in adipocytes isolated from the
subcutaneous adipose tissue of obese subjects was 50% lower
than the β-carotene concentrations measured in normal-weight
or nonobese subjects. Moreover, we propose that since obesity
predisposes to higher concentrations of oxidative stress and
inflammation, carotenoids, serving as local antioxidants and
a source for retinoic acid, may consequently be depleted
in obesity, which may explain the lower concentrations of
carotenoids in the circulation and the adipose tissue found
here.
Previous studies have reported the presence of carotenoid
isomers in plasma. The biological role of the different
carotenoid isomers is unclear. Our work has demonstrated that
9-cis, but not all-trans β-carotene, protects against atherogenesis in mouse models of atherosclerosis (33). Moreover, it is well
established that 9-cis retinoic acid binds specifically to retinoid

commercial standards, and the concentration of adipose tissue
lycopene could have been underestimated.
In conclusion, we report favorable relations between serum
and adipose tissue carotenoids and metabolic health in human.
The tissue-specific roles of the various carotenoids and their
stereoisomers should be further investigated in preclinical
models.
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